› Forums › General Melanoma Community › Iovance Biotherapeutics and TIL Survey
- This topic has 0 replies, 1 voice, and was last updated 3 years, 7 months ago by ljohnston.
- Post
-
- April 9, 2021 at 11:55 am
LAST CHANCE to help our partners at Iovance Biotherapeutics to learn more about your understanding and perspective of TIL Therapy. In support, the MRF is conducting a survey that is open to patients, thrivers and survivors who were diagnosed with stage III to stage IV unresectable melanoma. Follow the link to learn more: https://buff.ly/3fg8eSU
- You must be logged in to reply to this topic.